share_log

再鼎医药(09688.HK)拟5月9日(香港时间)举行董事会会议审批一季度业绩

Zaiding Pharmaceutical (09688.HK) plans to hold a board meeting on May 9 (Hong Kong time) to approve the first quarter results

Gelonghui Finance ·  Apr 26 16:52

Gelonghui, April 26, 丨 Zaiding Pharmaceutical (09688.HK) announced that the Board Review Committee will review and approve (including) the unaudited quarterly results (“First Quarter Results”) of the Company and its subsidiaries for the 3 months ended March 31, 2024, prepared in accordance with US GAAP and applicable rules of the US Securities and Exchange Commission (“First Quarter Results”).

If the first quarter results are approved by the Audit Committee, the company will publish the first quarter results announcement on the Hong Kong Stock Exchange Limited website on May 8, 2024 (Wednesday, US Eastern Time) /May 9, 2024 (Thursday, Hong Kong time).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment